Total planned funding: $40,438,280
Allocations
Countries/Regions
| Central Asia Region | $40,438,280 |
Organizational Types
| Own Agency | $14,069,627 |
| University | $7,612,007 |
| Unknown | $7,342,074 |
| NGO | $4,552,176 |
| Host Country Government Agency | $4,112,396 |
| Private Contractor | $2,050,000 |
| Multi-lateral Agency | $700,000 |
| Implementing Agency | $0 |
| Other USG Agency | $0 |
Program Areas
| Prevention | $10,503,074 |
| Management and Operations | $9,443,230 |
| Governance and Systems | $7,610,250 |
| Care | $5,995,451 |
| Treatment | $4,330,979 |
| Testing | $2,555,296 |
Budget Codes
| HVMS: Management and Operations | $9,443,230 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,460,208 |
| HBHC: Care: Adult Care and Support | $4,993,060 |
| HTXS: Treatment: Adult Treatment | $4,271,790 |
| HLAB: Laboratory Infrastructure | $3,555,333 |
| HVCT: Testing: HIV Testing and Counseling | $2,555,296 |
| OHSS: Health Systems Strengthening | $2,032,371 |
| HVSI: Strategic Information | $2,022,546 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $1,544,909 |
| HVTB: Care: TB/HIV | $1,002,391 |
| HMBL: Biomedical Prevention: Blood Safety | $407,738 |
| HMIN: Biomedical Prevention: Injection Safety | $90,219 |
| HTXD: Treatment: ARV Drugs | $59,189 |
Top Partner Programs
USG Aggregated Agencies:
$8,707,264
Countries/Regions
Central Asia Region
| 2010 | $3,180,975 |
| 2016 | $4,126,289 |
| 2017 | $1,400,000 |
Columbia University:
$7,612,007
Countries/Regions
Central Asia Region
| 2014 | $1,051,915 |
| 2016 | $3,397,092 |
| 2017 | $3,163,000 |
Ministry of Health - Kyrgyz Republic:
$3,902,396
Countries/Regions
Central Asia Region
| 2014 | $910,000 |
| 2016 | $1,620,396 |
| 2017 | $1,372,000 |
U.S. Centers for Disease Control and Prevention:
$2,983,204
Countries/Regions
Central Asia Region
| 2014 | $2,983,204 |